Bioventus Inc. — Director's Dealing 2021

Feb 12, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Bioventus Inc. (BVS)
CIK: 0001665988
Period of Report: 2021-02-11

Reporting Person: CHURCH KATRINA J (SVP & Chief Compliance Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$13.00	2031-02-10	Class A Common Stock (98850)		Direct
Employee Stock Option (right to buy)	$13.00	2031-02-10	Class A Common Stock (32950)		Direct

Footnotes

F1: The option vests in four equal installments beginning on the first anniversary of the grant date.

F2: The option vests in two equal installments beginning on the first anniversary of the grant date.